USMF logo

Institutional Repository in Medical Sciences
of Nicolae Testemitanu State University of Medicine and Pharmacy
of the Republic of Moldova
(IRMS – Nicolae Testemitanu SUMPh)

Biblioteca Stiintifica Medicala
DSpace

University homepage  |  Library homepage

 
 
Please use this identifier to cite or link to this item: http://hdl.handle.net/20.500.12710/19464
Full metadata record
DC FieldValueLanguage
dc.contributor.authorCurudimov, Mihail
dc.contributor.authorMihalache, Georgeta
dc.date.accessioned2021-12-17T13:59:47Z
dc.date.available2021-12-17T13:59:47Z
dc.date.issued2014
dc.identifier.citationCURUDIMOV, Mihail, MIHALACHE, Georgeta. Metabolic syndrome and hyperuricemia. In: MedEspera: the 5th Internat. Medical Congress for Students and Young Doctors: abstract book. Chișinău: S. n., 2014, p. 66.en_US
dc.identifier.urihttp://repository.usmf.md/handle/20.500.12710/19464
dc.descriptionState Medical and Pharmaceutical University “Nicolae Testemitanu”, Chisinau, Republic of Moldovaen_US
dc.description.abstractIntroduction: Metabolic syndrome comprises several abnormalities that occur together: general or central adiposity, elevated blood pressure, dyslipidemia, and hyperglycemia. In addition, several other abnormalities including those of fibrinolysis, thrombosis, inflammation, and endothelial function are strongly related to the syndrome. Elevated serum uric acid levels are commonly seen in association with glucose intolerance, hypertension, and dyslipidemia. Accumulated evidence have also demonstrated that serum levels of uric acid have a significant correlation with obesity and complications of metabolic syndrome. Materials and methods: In our study were selected about 200 patients with grade land 2 hypertension aged up to 65 years. The diagnosis of metabolic syndrome was established according to the proposed criteria based on WHO recommendations (1998), NCEP / ATP III (2005) and IDF (2005). We evaluated uric acid levels and hyperuricemia in patients with MS. Results: In researched group was established a significant prevalence (57.7%) of hyperuricemia in patients with metabolic syndrome. It was noted a proportional correlation of hyperuricemia and insulin ressistance with increasing obesity degree. The same tendency was noted to the mean plasma levels of uric acid in patients with metabolic syndrome. In patients with hyperuricemia average values of the atherogenic lipid fractions (TC, TG, LDL-C) were significantly higher than in those with normouricemia and the corresponding values of HDL-C were lower, while the TC and LDL-C levels in patients with hyperuricemia exceeded the normative recommended by NCEP. It was also noted that in the group of persons with hyperuricemia, hypertrigliceridemia met 2.79 times more frequently than in individuals with normal levels of uric acid and the probability of hypertrigliceridemia in the presence of hyperuricemia was almost 3.21 times higher. Conclusion: Hyperuricemia, considered an index of metabolic disorders, was noted in 57.8% of metabolic syndrome patients and significantly correlated with the values of lipid indices (TG, LDL-cholesterol), basal glucose levels, blood pressure values and indices of obesity (body mass index and waist circumference).en_US
dc.language.isoenen_US
dc.publisherMinistry of Health of the Republic of Moldova, State Medical and Pharmaceutical University Nicolae Testemitanu, Medical Students and Residents Associationen_US
dc.relation.ispartofMedEspera: The 5th International Medical Congress for Students and Young Doctors, May 14-17, 2014, Chisinau, Republic of Moldovaen_US
dc.subjectMetabolic syndromeen_US
dc.subjecthyperuricemiaen_US
dc.titleMetabolic syndrome and hyperuricemiaen_US
dc.typeOtheren_US
Appears in Collections:MedEspera 2014

Files in This Item:
File Description SizeFormat 
METABOLIC_SYNDROME_AND_HYPERURICEMIA.pdf62.82 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

 

Valid XHTML 1.0! DSpace Software Copyright © 2002-2013  Duraspace - Feedback